Physician
Michael a Flores M.D., P.A
Michael a Flores M.D., P.A was paid $972K by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99444, — 44% of everything it billed.
33Billing provider infoMICHAEL A FLORES M.D., P.A
DONNA, TX 78537
DONNA, TX 78537
33aNPI1609930809assigned 12/21/2006
33bProvider typeInternal Medicine Physician
28Total paid$972K
24GClaims54,612
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Texas
Rank by total paid#38 of 1,028
Median peer was paid$10K
This provider vs. median93×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,716 | $283K | |
| 2019 | 14,198 | $199K | |
| 2020 | 7,756 | $63K | |
| 2021 | 5,839 | $113K | |
| 2022 | 5,533 | $178K | |
| 2023 | 3,102 | $85K | |
| 2024incomplete | 1,468 | $51K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99444 | 44% | 7,539 | 1,924 | $429K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 11,138 | 8,290 | $258K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 4,424 | 3,637 | $104K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 6.2% | 578 | 562 | $60K |
| 99421 | 4.2% | 2,595 | 659 | $41K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 483 | 431 | $17K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 205 | 173 | $8K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 31 | 31 | $8K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 260 | 254 | $8K |
| 95927 | <1% | 363 | 363 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 754 | 677 | $6K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 292 | 53 | $5K |
53 more codes
| 95943 | <1% | 363 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 203 | $4K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 41 | $3K |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 973 | $2K |
| 93922 | <1% | 361 | $1K | |
| 0071A | <1% | 26 | $960.00 | |
| 0001A | <1% | 31 | $858.00 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $723.96 |
| 0004A | <1% | 17 | $638.00 | |
| 93000 | <1% | 120 | $531.70 | |
| 0002A | <1% | 20 | $514.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 33 | $433.07 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 41 | $418.38 |
| 0072A | <1% | 14 | $400.00 | |
| 90686 | <1% | 52 | $372.57 | |
| 99091 | <1% | 813 | $312.86 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $156.66 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 223 | $149.55 |
| 81002 | <1% | 250 | $137.74 | |
| S8301 | Infection control supplies, not otherwise specified | <1% | 26 | $115.49 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 83 | $34.25 |
| 82962 | <1% | 966 | $25.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 31 | $7.01 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.21 |
| 91301 | <1% | 72 | $0.02 | |
| 95117 | 0% | 62 | $0.00 | |
| 3017F | 0% | 303 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 4,680 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 767 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 92 | $0.00 |
| 3044F | 0% | 47 | $0.00 | |
| 1036F | 0% | 888 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 246 | $0.00 |
| 0509F | 0% | 126 | $0.00 | |
| 91307 | 0% | 40 | $0.00 | |
| 1124F | 0% | 629 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 3,480 | $0.00 |
| 4040F | 0% | 487 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 6,112 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 597 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,142 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 372 | $0.00 |
| 3045F | 0% | 41 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 86 | $0.00 |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 169 | $0.00 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 0% | 31 | $0.00 |
| 3046F | 0% | 462 | $0.00 | |
| 91300 | 0% | 69 | $0.00 | |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education | 0% | 26 | $0.00 |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 19 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 94 | $0.00 |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 21 | $0.00 |
| 4004F | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAMPOS, JOANNE (ADMINISTRATOR)